Frontiers in Pharmacology | Gastrointestinal and Hepatic Pharmacology

Original Research

Published on 01 Mar 2024

The effects of Massa Medicata Fermentata on the digestive function and intestinal flora of mice with functional dyspepsia

in Gastrointestinal and Hepatic Pharmacology

Shuyu Wang
Yuanlin Li
Xiaoqi Yang
Yinxue Hao
Xueyan Zhan

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1359954

3,273 views
3 citations

Review

Published on 29 Feb 2024

Nobiletin from citrus peel: a promising therapeutic agent for liver disease-pharmacological characteristics, mechanisms, and potential applications

in Gastrointestinal and Hepatic Pharmacology

Yongkang Cheng
Sansan Feng
Chuqiao Sheng
Chunfeng Yang
Yumei Li

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1354809

8,650 views
10 citations

Original Research

Published on 23 Feb 2024

Taurohyocholic acid acts as a potential predictor of the efficacy of tyrosine kinase inhibitors combined with programmed cell death-1 inhibitors in hepatocellular carcinoma

in Gastrointestinal and Hepatic Pharmacology

Yue Chen
Yutao Wang
Jin Lei
Bowen Chen
Xinfeng Zhang
Liangzheng Chang
Zhangli Hu
Yun Wang
Yinying Lu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1364924

2,215 views

Original Research

Published on 23 Feb 2024

Associations between one-carbon metabolism and valproic acid-induced liver dysfunction in epileptic patients

in Gastrointestinal and Hepatic Pharmacology

Jingwei Zhu
Zhe Wang
Xiaotong Sun
Dan Wang
Xinbo Xu
Liping Yang
Jiangdong Du
Zhimei Zhou
Yanhua Qi
Linfeng Ma

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1358262

1,916 views
2 citations

Review

Published on 23 Feb 2024

Evolving role of semaglutide in NAFLD: in combination, weekly and oral administration

in Gastrointestinal and Hepatic Pharmacology

Evgenia Koureta
Evangelos Cholongitas

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1343587

7,534 views
4 citations

Clinical Trial

Published on 19 Feb 2024

The safety and efficacy of Houtou Jianweiling tablet in patients with chronic non-atrophic gastritis: a double-blind, non-inferiority, randomized controlled trial

in Gastrointestinal and Hepatic Pharmacology

Muhammad Raza Shah
Samreen Fatima
Sehrosh Naz Khan
Shafiullah
Zahid Azam
Hafeezullah Shaikh
Shahid Majid
He Chengdong
Zhou Daijun
Wei Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1293272

3,669 views
1 citation

Original Research

Published on 15 Feb 2024

A nomogram prognostic model for early hepatocellular carcinoma with diabetes mellitus after primary liver resection based on the admission characteristics

in Gastrointestinal and Hepatic Pharmacology

Menghan Zhang
Qi Wang
Gongming Zhang
Guangming Li
Ronghua Jin
Huichun Xing

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1360478

1,542 views

Original Research

Published on 14 Feb 2024

Network pharmacology and gut microbiota insights: unraveling Shenling Baizhu powder’s role in psoriasis treatment

in Gastrointestinal and Hepatic Pharmacology

Bin Tang
Xuwei Zheng
Qianqian Luo
Xiong Li
Yujie Yang
Yang Bi
Yonggen Chen
Ling Han
Haiming Chen
Chuanjian Lu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1362161

5,911 views
9 citations

Original Research

Published on 01 Feb 2024

Sesamin ameliorates nonalcoholic steatohepatitis through inhibiting hepatocyte pyroptosis in vivo and in vitro

in Gastrointestinal and Hepatic Pharmacology

Teng Zhang
Yong Zhou
Yan Zhang
De-Guo Wang
Qiu-Yue Lv
Wen Wang
Ya-Ping Bai
Qiang Hua
Li-Qun Guo

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1347274

2,134 views
3 citations

Original Research

Published on 01 Feb 2024

Chishao (Paeoniae Radix Rubra) alleviates intra-hepatic cholestasis by modulating NTCP in rats

in Gastrointestinal and Hepatic Pharmacology

Xiaoqi Sun
Jing Fang
Nanyuan Fang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1341651

1,777 views
4 citations

Editorial

Published on 15 Jan 2024

Editorial: Advances in novel drugs and targets for hepatic and gastrointestinal diseases

in Gastrointestinal and Hepatic Pharmacology

Ebenezeri Erasto Ngowi
Yong Gao
Xiaoying Yang
Aijun Qiao

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1364290

1,194 views

Original Research

Published on 11 Jan 2024

Utilizing multimodal mass spectrometry imaging for profiling immune cell composition and N-glycosylation across colorectal carcinoma disease progression

in Gastrointestinal and Hepatic Pharmacology

Lyndsay E. A. Young
Paul J. Nietert
Rachel Stubler
Caroline G. Kittrell
Grace Grimsley
David N. Lewin
Anand S. Mehta
Chadi Hajar
Katherine Wang
Elizabeth C. O’Quinn

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1337319

4,065 views
8 citations

Systematic Review

Published on 11 Jan 2024

Comparative efficiency and safety of potassium competitive acid blockers versus Lansoprazole in peptic ulcer: a systematic review and meta-analysis

in Gastrointestinal and Hepatic Pharmacology

Yongqi Dong
Hongyan Xu
Zhihuan Zhang
Zhihang Zhou
Qiang Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1304552

6,574 views
9 citations

Systematic Review

Published on 10 Jan 2024

A bibliometric and visual analysis of the use of ustekinumab in Crohn’s disease using CiteSpace

in Gastrointestinal and Hepatic Pharmacology

Yi Chen
Jiaqi Zhang
Junling Wu
Hanwen Zhang
Zhe Luan
Zhizhuang Zhao
Congyong Li
Yiming Zhao
Hu Zhang
Shufang Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1322319

3,903 views
5 citations

Original Research

Published on 09 Jan 2024

Dimethyloxalylglycine pretreatment of living donor alleviates both donor and graft liver ischemia-reperfusion injury in rats

in Gastrointestinal and Hepatic Pharmacology

Degong Jia
Minjie Zhao
Jiefu Luo
Shengwei Li
Jianping Gong
Mingxiang Cheng

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1341575

1,563 views

Editorial

Published on 08 Jan 2024

Editorial: Women in gastrointestinal and hepatic pharmacology 2022

in Gastrointestinal and Hepatic Pharmacology

Eleonora Lai
Jessica Williams
Raquel Abalo
Daniela Gabbia

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1359135

984 views